RetractionWatch-Flagged.pdf

Recommendations

Relevance analysis suggests additional references and improvement opportunities. Use [R#] markers to jump to the full reference list below.

To strengthen this review, the primary focus should be on integrating foundational clinical data from early 2020 outbreaks [R48, R51] to ground the introduction in established epidemiological facts. Priority 2 involves deepening the discussion on the specific mechanisms of kidney injury, particularly by incorporating more recent narrative reviews [R54, R58] that synthesize multi-organ damage. Finally, Priority 3 suggests justifying the use of older, non-COVID specific citations [R30, R31] to ensure the review remains focused on the current pandemic's unique renal challenges.

Top priorities

1. Priority 1: Add early clinical data from Wuhan to provide a more robust baseline for the initial outbreak description. - Insert this after the mention of the virus being described as a coronavirus in early January.

   Add

   This is a foundational study that established the first clinical features of the virus.

   On January 7, the virus was described as a coronavirus [1].

   Supporting refs: [R48]

2. Priority 2: Include specific hospitalization statistics to support the severity of pneumonia and renal involvement. - Add this when discussing the severity of illness and the impact on the kidney.

   Add

   It provides essential context on the scale of organ failure seen in early hospitalized patients.

   the kidney is among the different organs that are significantly affected with the SARS-CoV-2 infection [2,3].

   Supporting refs: [R51]

3. Priority 3: Address the conflicting evidence regarding direct viral presence in renal tissue - In section 2.1, after the discussion of US autopsies

   Justify

   The text presents viral particles in podocytes as fact, but other high-quality studies in the references could not distinguish definitive virions, suggesting a need for a more balanced discussion.

   definitive virions could not be distinguished at the ultrastructural level [29]

   Supporting refs: [R79], [R109]

4. Priority 4: Integrate ICU-specific AKI incidence and mortality predictors - In section 2.2, after the mention of ICU AKI rates

   Add

   It provides specific clinical markers (albumin, age, comorbidities) that correlate with AKI-related mortality in the ICU.

   AKI rates were significantly elevated to 14.5-50% in patients in the ICU

   Supporting refs: [R43]

5. Priority 5: Integrate recent epidemiological insights on kidney disease progression - At the end of the first paragraph of section 3

   Add

   It provides a comprehensive 2022 perspective on how COVID-19 transitions from acute injury to long-term kidney disease.

   functional decline in the majority of seriously impacted patients [83,84].

   Supporting refs: [R45]

Other changes by section

Derived from citation-coupled works that cite many of your references.

Complete reference list

All deep-analysis references, alphabetized by author. Use the filter to show only references from a given group.

1. [R100] Adamsick, M. L., Gandhi, R. G., Bidell, M. R., Elshaboury, R. H., Bhattacharyya, R. P., et al. (2020). Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. Journal of the American Society of Nephrology, 31(7), 1384–1386.
   Source: Journal of the American Society of Nephrology
   DOI: 10.1681/asn.2020050589
   Already cited
2. [R113] Adapa, S., Chenna, A., Balla, M., Merugu, G. P., Koduri, N. M., et al. (2020). COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation. Journal of Clinical Medicine Research, 12(6), 352–361.
   Source: Journal of Clinical Medicine Research
   DOI: 10.14740/jocmr4200 Open PDF
   Already cited
3. [R218] Agís‐Balboa, R. C. & Fischer, A. (2013). Generating new neurons to circumvent your fears: the role of IGF signaling.
   Source: Cellular and Molecular Life Sciences
   DOI: 10.1007/s00018-013-1316-2
4. [R24] Ahmadian, E., Khatibi, S. M. H., Soofiyani, S. R., Abediazar, S., Shoja, M. M., et al. (2020). Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms. Reviews in Medical Virology, 31(3), e2176.
   Source: Reviews in Medical Virology
   DOI: 10.1002/rmv.2176 Open PDF
   Already cited
5. [R135] Ahmed, H., Patel, K., Greenwood, D. C., Halpin, S., Lewthwaite, P., et al. (2020). LONG-TERM CLINICAL OUTCOMES IN SURVIVORS OF CORONAVIRUS OUTBREAKS AFTER HOSPITALISATION OR ICU ADMISSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF FOLLOW-UP STUDIES.
   DOI: 10.1101/2020.04.16.20067975 Open PDF
   Already cited
6. [R13] Ajaimy, M. & Melamed, M. L. (2020). COVID-19 in Patients with Kidney Disease. Clinical Journal of the American Society of Nephrology, 15(8), 1087–1089.
   Source: Clinical Journal of the American Society of Nephrology
   DOI: 10.2215/cjn.09730620
   Already cited
7. [R107] Akalin, E., Azzi, Y. A., Bartash, R., Seethamraju, H., Parides, M. K., et al. (2020). Covid-19 and Kidney Transplantation. New England Journal of Medicine, 382(25), 2475–2477.
   Source: New England Journal of Medicine
   DOI: 10.1056/nejmc2011117
   Already cited
8. [R90] Akilesh, S., Nast, C. C., Yamashita, M., Henriksen, K., Charu, V., et al. (2020). Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. American Journal of Kidney Diseases, 77(1), 82–93.e1.
   Source: American Journal of Kidney Diseases
   DOI: 10.1053/j.ajkd.2020.10.001
   Already cited
9. [R149] Alberici, F., Delbarba, E., Manenti, C., Econimo, L., Valerio, F., et al. (2020). A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney International, 97(6), 1083–1088.
   Source: Kidney International
   DOI: 10.1016/j.kint.2020.04.002 Open PDF
   Already cited
10. [R70] Anandh, U., Noorin, A., Kazmi, S. K. S., Bannur, S., Shah, S. S. A., et al. (2022). Acute kidney injury in critically ill COVID-19 infected patients requiring dialysis: experience from India and Pakistan. BMC Nephrology, 23(1), 308.
    Source: BMC Nephrology
    DOI: 10.1186/s12882-022-02931-3 Open PDF
    Already cited
11. [R145] Anderegg, M., Liu, M., Saganas, C., Montani, M., Vogt, B., et al. (2021). De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney International, 100(2), 474–476.
    Source: Kidney International
    DOI: 10.1016/j.kint.2021.05.016 Open PDF
    Already cited
12. [R186] Anderson, R. M., Fraser, C., Ghani, A. C., Donnelly, C. A., Riley, S., et al. (2004). Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic.
    Source: Philosophical Transactions of the Royal Society B Biological Sciences
    DOI: 10.1098/rstb.2004.1490
13. [R253] Angus, D. C., Linde‐Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J. A., & Pinsky, M. R. (2001). Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care.
    Source: Critical Care Medicine
    DOI: 10.1097/00003246-200107000-00002
14. [R46] Ansems, K., Grundeis, F., Dahms, K., Mikołajewska, A., Thieme, V., et al. (2021). Remdesivir for the treatment of COVID-19. Cochrane Database of Systematic Reviews, 2021(8), CD014962.
    Source: Cochrane Database of Systematic Reviews
    DOI: 10.1002/14651858.cd014962
    Already cited
15. [R151] Apóstolo, J. L. A., Mendes, A. C., & Azeredo, Z. A. (2006). Adaptation to Portuguese of the Depression, Anxiety and Stress Scales (DASS).
    Source: Revista Latino-Americana de Enfermagem
    DOI: 10.1590/s0104-11692006000600006 Open PDF
16. [R65] Aref, A., Valizadeh, Z., Sakiani, M., Maleknia, M., Arani, Z. S., & Kazemi, H. (2023). Acute Renal Failure in a Patient with Coronavirus: A Case Report of a Rarely-Seen Presentation.
    Source: Gene Cell and Tissue
    DOI: 10.5812/gct-135159 Open PDF
17. [R14] Arentz, M., Yim, E., Klaff, L. S., Lokhandwala, S., Riedo, F. X., et al. (2020). Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA, 323(16), 1612.
    Source: JAMA
    DOI: 10.1001/jama.2020.4326 Open PDF
    Already cited
18. [R215] Assiri, A. M., Al‐Tawfiq, J. A., Al-Rabeeah, A. A., Alrabiah, F., Al-Hajjar, S., et al. (2013). Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.
    Source: The Lancet Infectious Diseases
    DOI: 10.1016/s1473-3099(13)70204-4 Open PDF
19. [R140] Azzolini, E., Levi, R., Sarti, R., Pozzi, C., Mollura, M., et al. (2022). Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA, 328(7), 676.
    Source: JAMA
    DOI: 10.1001/jama.2022.11691 Open PDF
    Already cited
20. [R205] Bagshaw, S. M., Sood, M. M., Long, J., Fowler, R., Adhikari, N. K., & Collaborative, C. C. C. T. G. H. (2013). Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study.
    Source: BMC Nephrology
    DOI: 10.1186/1471-2369-14-123 Open PDF
21. [R183] Basu, R. K. & Wheeler, D. S. (2013). Kidney–lung cross-talk and acute kidney injury.
    Source: Pediatric Nephrology
    DOI: 10.1007/s00467-012-2386-3 Open PDF
22. [R43] Bayrakçı, N., Özkan, G., Şakacı, M., Sedef, S., Erdem, İ., et al. (2022). The incidence of acute kidney injury and its association with mortality in patients diagnosed with<scp>COVID</scp>‐19 followed up in intensive care unit. Therapeutic Apheresis and Dialysis, 26(5), 889–896.
    Source: Therapeutic Apheresis and Dialysis
    DOI: 10.1111/1744-9987.13790
    Already cited
23. [R132] Betti, M., Bertolotti, M., Ferrante, D., Roveta, A., Pelazza, C., et al. (2021). Baseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged ≤ 65 years: A retrospective observational study. PLoS ONE, 16(3), e0248829.
    Source: PLoS ONE
    DOI: 10.1371/journal.pone.0248829
    Already cited
24. [R62] Birkelo, B. C., Parr, S. K., Perkins, A. M., Greevy, R. A., Hung, A. M., et al. (2021). Comparison of COVID-19 versus influenza on the incidence, features, and recovery from acute kidney injury in hospitalized United States Veterans. Kidney International, 100(4), 894–905.
    Source: Kidney International
    DOI: 10.1016/j.kint.2021.05.029 Open PDF
    Already cited
25. [R94] Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G., et al. (2020). Angiotensin‐converting enzyme 2 (<scp>ACE2</scp>), <scp>SARS‐CoV</scp>‐2 and the pathophysiology of coronavirus disease 2019 (<scp>COVID</scp>‐19). The Journal of Pathology, 251(3), 228–248.
    Source: The Journal of Pathology
    DOI: 10.1002/path.5471 Open PDF
    Already cited
26. [R110] Brealey, J. & Miller, S. (2020). SARS‐CoV‐2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions. British Journal of Dermatology, 184(1), 186.
    Source: British Journal of Dermatology
    DOI: 10.1111/bjd.19572 Open PDF
    Already cited
27. [R38] Brill, A., Chauhan, A. K., Canault, M., Walsh, M., Bergmeier, W., & Wagner, D. D. (2009). Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovascular Research, 84(1), 137–144.
    Source: Cardiovascular Research
    DOI: 10.1093/cvr/cvp176 Open PDF
    Already cited
28. [R64] Brogan, M. & Ross, M. J. (2021). The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit. ˜The œNephron journals/Nephron journals, 146(1), 67–71.
    Source: ˜The œNephron journals/Nephron journals
    DOI: 10.1159/000519530 Open PDF
    Already cited
29. [R214] Buchert, R. (2005). Adjusted Scaling of FDG Positron Emission Tomography Images for Statistical Evaluation in Patients With Suspected Alzheimer's Disease.
    Source: Journal of Neuroimaging
    DOI: 10.1177/1051228405280169
30. [R264] Bäder, M. (2012). ACE2, angiotensin-(1–7), and Mas: the other side of the coin.
    Source: Pflügers Archiv - European Journal of Physiology
    DOI: 10.1007/s00424-012-1120-0
31. [R66] Bălan, C., Ciuhodaru, T., & Bubenek-Turconi, Ş. (2023). Kidney Injury in Critically Ill Patients with COVID-19 – From Pathophysiological Mechanisms to a Personalized Therapeutic Model.
    Source: ˜The œJournal of Critical Care Medicine
    DOI: 10.2478/jccm-2023-0023 Open PDF
32. [R89] Carsana, L., Sonzogni, A., Nasr, A., Rossi, R., Pellegrinelli, A., et al. (2020). Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases, 20(10), 1135–1140.
    Source: The Lancet Infectious Diseases
    DOI: 10.1016/s1473-3099(20)30434-5 Open PDF
    Already cited
33. [R40] Carvalho, H. D., Richard, M. C., Chouihed, T., Goffinet, N., Bastard, Q. L., et al. (2021). Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case–control study. Internal and Emergency Medicine, 16(7), 1945–1950.
    Source: Internal and Emergency Medicine
    DOI: 10.1007/s11739-021-02632-z Open PDF
    Already cited
34. [R36] Castellano, G., Cafiero, C., Divella, C., Sallustio, F., Gigante, M., et al. (2015). Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells. Arthritis Research & Therapy, 17(1), 72.
    Source: Arthritis Research & Therapy
    DOI: 10.1186/s13075-015-0588-3
    Already cited
35. [R161] Cazzola, M., Bergamaschi, G., Tonon, L., Arbustini, E., Grasso, M., et al. (1997). Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA.
    Source: Blood
    DOI: 10.1182/blood.v90.2.814 Open PDF
36. [R268] Chang, S., Lee, C., Lin, P., Huang, H., Chang, L., et al. (2007). A community‐derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005.
    Source: Journal of Medical Virology
    DOI: 10.1002/jmv.21045 Open PDF
37. [R227] Chatterjee, S., Nieman, G. F., Christie, J. D., & Fisher, A. B. (2014). Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.
    Source: American Journal of Physiology-Lung Cellular and Molecular Physiology
    DOI: 10.1152/ajplung.00198.2014
38. [R17] Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C. (2020). The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovascular Research, 116(6), 1097–1100.
    Source: Cardiovascular Research
    DOI: 10.1093/cvr/cvaa078 Open PDF
    Already cited
39. [R12] Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513.
    Source: The Lancet
    DOI: 10.1016/s0140-6736(20)30211-7 Open PDF
    Already cited
40. [R255] Chen, Y., Rubin, P., Williams, J. S., Hernady, E., Smudzin, T., & Okunieff, P. (2001). Circulating IL-6 as a predictor of radiation pneumonitis.
    Source: International Journal of Radiation Oncology*Biology*Physics
    DOI: 10.1016/s0360-3016(00)01445-0
41. [R251] Chiang, S., Lin, T., Chow, K., & Chiou, S. (2010). SARS spike protein induces phenotypic conversion of human B cells to macrophage-like cells.
    Source: Molecular Immunology
    DOI: 10.1016/j.molimm.2010.06.014
42. [R232] Chu, H., Zhou, J., Wong, B. H., Li, C., Cheng, Z., et al. (2014). Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response.
    Source: Virology
    DOI: 10.1016/j.virol.2014.02.018
43. [R202] Chu, K. H., Tsang, W. K., Tang, C., Lam, M. F., Lai, F. M., et al. (2005). Acute renal impairment in coronavirus-associated severe acute respiratory syndrome.
    Source: Kidney International
    DOI: 10.1111/j.1523-1755.2005.67130.x Open PDF
44. [R237] Coca, S. G., Yusuf, B., Shlipak, M. G., Garg, A. X., & Parikh, C. R. (2009). Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis.
    Source: American Journal of Kidney Diseases
    DOI: 10.1053/j.ajkd.2008.11.034
45. [R265] Corti, M. (1994). Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons.
    Source: JAMA
    DOI: 10.1001/jama.1994.03520130074036
46. [R231] Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., et al. (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function.
    Source: Nature
    DOI: 10.1038/nature00786
47. [R266] Croft, M., So, T., Duan, W., & Soroosh, P. (2009). The significance of OX40 and OX40L to T‐cell biology and immune disease.
    Source: Immunological Reviews
    DOI: 10.1111/j.1600-065x.2009.00766.x
48. [R170] Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., et al. (2015). The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.
    Source: Immunity
    DOI: 10.1016/j.immuni.2015.08.010 Open PDF
49. [R131] Cruces, P., Lillo, P., Salas, C., Salomón, T., Lillo, F., et al. (2017). Renal Decapsulation Prevents Intrinsic Renal Compartment Syndrome in Ischemia-Reperfusion–Induced Acute Kidney Injury: A Physiologic Approach*. Critical Care Medicine, 46(2), 216–222.
    Source: Critical Care Medicine
    DOI: 10.1097/ccm.0000000000002830
    Already cited
50. [R182] Cruz‐Lagunas, A., Jiménez-Álvarez, L., Ramírez, G., Mendoza-Milla, C., García-Sancho, M. C., et al. (2014). Obesity and pro-inflammatory mediators are associated with acute kidney injury in patients with A/H1N1 influenza and acute respiratory distress syndrome.
    Source: Experimental and Molecular Pathology
    DOI: 10.1016/j.yexmp.2014.10.006
51. [R261] Cybulsky, A. V., Takano, T., Papillon, J., Khadir, A., Liu, J., & Peng, H. (2002). Complement C5b-9 Membrane Attack Complex Increases Expression of Endoplasmic Reticulum Stress Proteins in Glomerular Epithelial Cells.
    Source: Journal of Biological Chemistry
    DOI: 10.1074/jbc.m204694200
52. [R257] Dalrymple, L. S., Mu, Y., Romano, P. S., Nguyen, D. V., Chertow, G. M., et al. (2015). Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis.
    Source: American Journal of Kidney Diseases
    DOI: 10.1053/j.ajkd.2014.11.030
53. [R150] Dancey, C. P. & Reidy, J. (1999). Statistics without maths for psychology.
    URL: http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=024522546&amp;sequence=000001&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA
54. [R33] Darmon, M., Schortgen, F., Vargas, F., Liazydi, A., Schlemmer, B., et al. (2010). Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Medicine, 37(1), 68–76.
    Source: Intensive Care Medicine
    DOI: 10.1007/s00134-010-2050-y
    Already cited
55. [R99] Dashtban, A., Mizani, M. A., Denaxas, S., Nitsch, D., Quint, J. K., et al. (2022). A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease. Kidney International, 102(3), 652–660.
    Source: Kidney International
    DOI: 10.1016/j.kint.2022.05.015 Open PDF
    Already cited
56. [R20] Datta (2020). A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection. JAMA.
    Source: JAMA
    DOI: 10.1001/jama.2020.22717
    Already cited
57. [R198] Davies, R. & Choy, E. (2014). Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis.
    Source: Seminars in Immunology
    DOI: 10.1016/j.smim.2013.12.002
58. [R195] Delvaeye, M. & Conway, E. M. (2009). Coagulation and innate immune responses: can we view them separately?.
    Source: Blood
    DOI: 10.1182/blood-2009-05-199208 Open PDF
59. [R196] Donnelly, C. A., Ghani, A. C., Leung, G., Hedley, A. J., Fraser, C., et al. (2003). Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.
    Source: The Lancet
    DOI: 10.1016/s0140-6736(03)13410-1 Open PDF
60. [R206] Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., et al. (2000). A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9.
    Source: Circulation Research
    DOI: 10.1161/01.res.87.5.e1 Open PDF
61. [R165] Dryden, M., Baguneid, M., Eckmann, C., Corman, S., Stephens, J., et al. (2015). Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections.
    Source: Clinical Microbiology and Infection
    DOI: 10.1016/j.cmi.2015.03.024 Open PDF
62. [R115] Du, F., Liu, B., & Zhang, Y. (2020). COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness. Journal of Thrombosis and Thrombolysis, 51(2), 313–329.
    Source: Journal of Thrombosis and Thrombolysis
    DOI: 10.1007/s11239-020-02224-2 Open PDF
    Already cited
63. [R130] Dupont, V., Gamblin, C., Bard, M., Gautier, J., Bonnivard, M., et al. (2021). Severe Intraabdominal Hypertension in Critically Ill COVID-19 Patients With Acute Kidney Injury. CHEST Journal, 160(2), 558–561.
    Source: CHEST Journal
    DOI: 10.1016/j.chest.2021.03.019 Open PDF
    Already cited
64. [R222] D’Agostino, R. B. & Rubin, D. B. (2000). Estimating and Using Propensity Scores with Partially Missing Data.
    Source: Journal of the American Statistical Association
    DOI: 10.1080/01621459.2000.10474263
65. [R152] Eklund, C. (2009). Chapter 5 Proinflammatory cytokines in CRP baseline regulation.
    Source: Advances in clinical chemistry
    DOI: 10.1016/s0065-2423(09)48005-3
66. [R263] Elixhauser, A., Steiner, C., Harris, D., & Coffey, R. M. (1998). Comorbidity Measures for Use with Administrative Data.
    Source: Medical Care
    DOI: 10.1097/00005650-199801000-00004
67. [R201] Eltzschig, H. K. & Carmeliet, P. (2011). Hypoxia and Inflammation.
    Source: New England Journal of Medicine
    DOI: 10.1056/nejmra0910283
68. [R213] Enderlein, G. (1987). Cox, D. R.; Oakes, D.: Analysis of Survival Data. Chapman and Hall, London – New York 1984, 201 S., £ 12,–.
    Source: Biometrical Journal
    DOI: 10.1002/bimj.4710290119
69. [R181] Erbaş, G., Oktar, S. Ö., Kılıç, K., Şen, İ., Budakoğlu, I. İ., & Araç, M. (2011). Unenhanced urinary CT: Value of parenchymal attenuation measurements in differentiating acute vs. chronic renal obstruction.
    Source: European Journal of Radiology
    DOI: 10.1016/j.ejrad.2011.02.029
70. [R4] Faour, W. H., Choaib, A., Issa, E., Choueiry, F. E., Shbaklo, K., et al. (2021). Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflammation Research, 71(1), 39–56.
    Source: Inflammation Research
    DOI: 10.1007/s00011-021-01520-8 Open PDF
    Already cited
71. [R26] Farouk (2020). COVID-19 and the kidney: what we think we know so far and what we don’t. Journal of Nephrology.
    Source: Journal of Nephrology
    DOI: 10.1007/s40620-020-00789-y
    Already cited
72. [R199] Feng, Y., Nikolić, N., Bakke, S. S., Boekschoten, M. V., Kersten, S., et al. (2013). PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
    Source: Archives of Physiology and Biochemistry
    DOI: 10.3109/13813455.2013.829105
73. [R236] Ferrario, C. M., Jessup, J. A., Chappell, M. C., Averill, D. B., Brosnihan, K. B., et al. (2005). Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2.
    Source: Circulation
    DOI: 10.1161/circulationaha.104.510461
74. [R34] Fischetti, F. & Tedesco, F. (2006). Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. Autoimmunity, 39(5), 417–428.
    Source: Autoimmunity
    DOI: 10.1080/08916930600739712
    Already cited
75. [R164] Force, A. D. T. (2012). Acute Respiratory Distress Syndrome.
    Source: JAMA
    DOI: 10.1001/jama.2012.5669
76. [R68] Gasparini, G., Canepa, P., Verdiani, S., Carmisciano, L., Cozzani, E., et al. (2021). A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients. International Journal of Immunopathology and Pharmacology, 35, 20587384211042115.
    Source: International Journal of Immunopathology and Pharmacology
    DOI: 10.1177/20587384211042115
    Already cited
77. [R108] Gautam, R. & Sharma, M. (2020). 2019-nCoV pandemic: A disruptive and stressful atmosphere for Indian academic fraternity. Brain Behavior and Immunity, 88, 948–949.
    Source: Brain Behavior and Immunity
    DOI: 10.1016/j.bbi.2020.04.025
    Already cited
78. [R169] Georgiades, C., Moore, C. J., & Smith, D. P. (2001). Differences of Renal Parenchymal Attenuation for Acutely Obstructed and Unobstructed Kidneys on Unenhanced Helical CT.
    Source: American Journal of Roentgenology
    DOI: 10.2214/ajr.176.4.1760965
79. [R112] Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J., et al. (2020). Response by Gheblawi et al to Letter Regarding Article, “Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2”. Circulation Research, 127(2), e46–e47.
    Source: Circulation Research
    DOI: 10.1161/circresaha.120.317332
    Already cited
80. [R272] Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E. J., et al. (2011). Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response.
    Source: Journal of Virology
    DOI: 10.1128/jvi.02232-10
81. [R246] Goldman, S. M., Faintuch, S., Ajzen, S., Christofalo, D. M. J., Araújo, M. P., et al. (2004). Diagnostic Value of Attenuation Measurements of the Kidney on Unenhanced Helical CT of Obstructive Ureterolithiasis.
    Source: American Journal of Roentgenology
    DOI: 10.2214/ajr.182.5.1821251
82. [R109] Golmai, P., Larsen, C. P., DeVita, M. V., Wahl, S. J., Weins, A., et al. (2020). Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19. Journal of the American Society of Nephrology, 31(9), 1944–1947.
    Source: Journal of the American Society of Nephrology
    DOI: 10.1681/asn.2020050683
    Already cited
83. [R136] Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020). Management of post-acute covid-19 in primary care. BMJ, 370, m3026.
    Source: BMJ
    DOI: 10.1136/bmj.m3026 Open PDF
    Already cited
84. [R49] Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China.
    Source: New England Journal of Medicine
    DOI: 10.1056/nejmoa2002032
85. [R21] Gupta, S., Hayek, S. S., Wang, W., Chan, L., Mathews, K. S., et al. (2020). Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Internal Medicine, 180(11), 1436.
    Source: JAMA Internal Medicine
    DOI: 10.1001/jamainternmed.2020.3596 Open PDF
    Already cited
86. [R271] Gurley, S. B., Allred, A. J., Le, T. H., Griffiths, R., Mao, L., et al. (2006). Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.
    Source: Journal of Clinical Investigation
    DOI: 10.1172/jci16980 Open PDF
87. [R125] Gérard, A. O., Laurain, A., Fresse, A., Parassol, N., Muzzone, M., et al. (2020). Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database. Clinical Pharmacology & Therapeutics, 109(4), 1021–1024.
    Source: Clinical Pharmacology & Therapeutics
    DOI: 10.1002/cpt.2145
    Already cited
88. [R207] Gómez, H., İnce, C., Backer, D. D., Pickkers, P., Payen, D., et al. (2013). A Unified Theory of Sepsis-Induced Acute Kidney Injury.
    Source: Shock
    DOI: 10.1097/shk.0000000000000052
89. [R54] Hachimi, A., El‐Mansoury, B., & Merzouki, M. (2025). Incidence, pathophysiology, risk factors, histopathology, and outcomes of COVID-19-induced acute kidney injury: A narrative review.
    Source: Microbial Pathogenesis
    DOI: 10.1016/j.micpath.2025.107360
90. [R171] Halekoh, U., Højsgaard, S., & Yan, J. (2006). The<i>R</i>Package<b>geepack</b>for Generalized Estimating Equations.
    Source: Journal of Statistical Software
    DOI: 10.18637/jss.v015.i02
91. [R134] Hamed, M. A. (2021). COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk. Coronaviruses, 2(10).
    Source: Coronaviruses
    DOI: 10.2174/2666796702666210202124650
    Already cited
92. [R69] Han, X., Xu, P., Wang, H., Mao, J., & Ye, Q. (2022). Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China. Journal of Infection, 84(4), 579–613.
    Source: Journal of Infection
    DOI: 10.1016/j.jinf.2022.01.007
    Already cited
93. [R147] Hanna, N. H., Schneider, B. J., Temin, S., Baker, S., Brahmer, J. R., et al. (2020). Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Journal of Clinical Oncology, 38(14), 1608–1632.
    Source: Journal of Clinical Oncology
    DOI: 10.1200/jco.19.03022
    Already cited
94. [R194] Hartmann, G., Tschöp, M., Fischer, R., Bidlingmaier, C., Riepl, R. L., et al. (2000). HIGH ALTITUDE INCREASES CIRCULATING INTERLEUKIN-6, INTERLEUKIN-1 RECEPTOR ANTAGONIST AND C-REACTIVE PROTEIN.
    Source: Cytokine
    DOI: 10.1006/cyto.1999.0533
95. [R9] Head, R., Lumbers, E. R., Jarrott, B., Tretter, F., Smith, G. R., et al. (2022). Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment. Pharmacology Research & Perspectives, 10(1), e00922.
    Source: Pharmacology Research & Perspectives
    DOI: 10.1002/prp2.922
    Already cited
96. [R190] Heemskerk, S., Masereeuw, R., Moesker, O., Bouw, M. P. W. J. M., Hoeven, J. G. V. D., et al. (2009). Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients*.
    Source: Critical Care Medicine
    DOI: 10.1097/ccm.0b013e31819598af
97. [R256] Helderman, J. H. (1997). New immunologically non-specific immunosuppressive agents dictate changes in standard protocols for renal transplant management.
    URL: https://pubmed.ncbi.nlm.nih.gov/9075229
98. [R119] Henry, B. M., Benoit, J. L., Berger, B. A., Pulvino, C., Lavie, C. J., et al. (2020). Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7. Journal of Medical Virology, 93(2), 678–680.
    Source: Journal of Medical Virology
    DOI: 10.1002/jmv.26479
    Already cited
99. [R148] Hilbrands, L. B., Duivenvoorden, R., Vart, P., Franssen, C., Hemmelder, M. H., et al. (2020). COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrology Dialysis Transplantation, 35(11), 1973–1983.
    Source: Nephrology Dialysis Transplantation
    DOI: 10.1093/ndt/gfaa261 Open PDF
    Already cited
100. [R77] Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma, P., Shah, H. H., et al. (2020). Acute kidney injury in patients hospitalized with COVID-19. Kidney International, 98(1), 209–218.
     Source: Kidney International
     DOI: 10.1016/j.kint.2020.05.006 Open PDF
     Already cited
101. [R247] Hitzemann, R. (1988). Thermodynamic aspects of drug-receptor interactions.
     Source: Trends in Pharmacological Sciences
     DOI: 10.1016/0165-6147(88)90068-5
102. [R159] Hozo, S. P., Djulbegović, B., & Hozo, I. (2005). Estimating the mean and variance from the median, range, and the size of a sample.
     Source: BMC Medical Research Methodology
     DOI: 10.1186/1471-2288-5-13 Open PDF
103. [R48] Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(20)30183-5 Open PDF
104. [R39] Hui, D. S. (2005). Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax, 60(5), 401–409.
     Source: Thorax
     DOI: 10.1136/thx.2004.030205 Open PDF
     Already cited
105. [R10] Hultström, M., Lipcsey, M., Wallin, E., Larsson, I., Larsson, A., & Frithiof, R. (2021). Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Critical Care, 25(1), 37.
     Source: Critical Care
     DOI: 10.1186/s13054-021-03461-4 Open PDF
     Already cited
106. [R269] Høstmark, A. T., Tomten, S. E., & Berg, J. (2005). Serum albumin and blood pressure: a population-based, cross-sectional study.
     Source: Journal of Hypertension
     DOI: 10.1097/01.hjh.0000163139.44094.1d
107. [R238] Iacus, S. M., King, G., & Porro, G. (2011). Causal Inference without Balance Checking: Coarsened Exact Matching.
     Source: Political Analysis
     DOI: 10.1093/pan/mpr013 Open PDF
108. [R32] Jia, H. P., Look, D. C., Tan, P., Shi, L., Hickey, M. A., et al. (2009). Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. American Journal of Physiology-Lung Cellular and Molecular Physiology, 297(1), L84–L96.
     Source: American Journal of Physiology-Lung Cellular and Molecular Physiology
     DOI: 10.1152/ajplung.00071.2009
     Already cited
109. [R203] Jin, H., Anderson, A. C., Tan, W. G., West, E. E., Ha, S., et al. (2010). Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
     Source: Proceedings of the National Academy of Sciences
     DOI: 10.1073/pnas.1009731107
110. [R172] Jin, H., Chen, L., Zhang, Z., Xu, Y., Song, B., et al. (2015). Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
     Source: Journal of Translational Medicine
     DOI: 10.1186/s12967-015-0616-8 Open PDF
111. [R117] Kai, H. & Kai, M. (2020). Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19. Hypertension Research, 43(7), 648–654.
     Source: Hypertension Research
     DOI: 10.1038/s41440-020-0455-8 Open PDF
     Already cited
112. [R137] Kampen, J. J. A. V., Vijver, D. V. D., Fraaij, P. L. A., Haagmans, B. L., Lamers, M. M., et al. (2021). Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nature Communications, 12(1), 267.
     Source: Nature Communications
     DOI: 10.1038/s41467-020-20568-4 Open PDF
     Already cited
113. [R37] Kato, S., Chmielewski, M. S., Honda, H., Pecoits‐Filho, R., Matsuo, S., et al. (2008). Aspects of Immune Dysfunction in End-stage Renal Disease. Clinical Journal of the American Society of Nephrology, 3(5), 1526–1533.
     Source: Clinical Journal of the American Society of Nephrology
     DOI: 10.2215/cjn.00950208
     Already cited
114. [R126] Kawakami (2021). Microthrombi as a Major Cause of Cardiac Injury in COVID-19. Circulation.
     Source: Circulation
     DOI: 10.1161/circulationaha.120.051828
     Already cited
115. [R158] Kellerman, J., Rigler, D., & Siegel, S. E. (1977). The psychological effects of isolation in protected environments.
     Source: American Journal of Psychiatry
     DOI: 10.1176/ajp.134.5.563
116. [R187] Kellum, J. A. (2011). Impaired renal blood flow and the ‘spicy food’ hypothesis of acute kidney injury*.
     Source: Critical Care Medicine
     DOI: 10.1097/ccm.0b013e31820f70bb
117. [R211] Kellum, J. A., Lameire, N., & Group, F. T. K. A. G. W. (2013). Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).
     Source: Critical Care
     DOI: 10.1186/cc11454 Open PDF
118. [R15] Kellum, J. A., Till, J. W. O. V., & Mulligan, G. (2020). Targeting acute kidney injury in COVID-19. Nephrology Dialysis Transplantation, 35(10), 1652–1662.
     Source: Nephrology Dialysis Transplantation
     DOI: 10.1093/ndt/gfaa231 Open PDF
     Already cited
119. [R262] Khaitan, A. & Unutmaz, D. (2010). Revisiting Immune Exhaustion During HIV Infection.
     Source: Current HIV/AIDS Reports
     DOI: 10.1007/s11904-010-0066-0 Open PDF
120. [R233] Khwaja, A. (2012). KDIGO Clinical Practice Guidelines for Acute Kidney Injury.
     Source: Nephron Clinical Practice
     DOI: 10.1159/000339789
121. [R209] Kim, K. D., Zhao, J., Auh, S., Yang, X., Du, P., et al. (2007). Adaptive immune cells temper initial innate responses.
     Source: Nature Medicine
     DOI: 10.1038/nm1633 Open PDF
122. [R156] Kim, S., Muntaner, C., Kim, H., Jeon, C. Y., & Perry, M. J. (2013). Gain of employment and depressive symptoms among previously unemployed workers: A longitudinal cohort study in South Korea.
     Source: American Journal of Industrial Medicine
     DOI: 10.1002/ajim.22201
123. [R80] Kissling, S., Rotman, S., Gerber, C., Halfon, M., Lamoth, F., et al. (2020). Collapsing glomerulopathy in a COVID-19 patient. Kidney International, 98(1), 228–231.
     Source: Kidney International
     DOI: 10.1016/j.kint.2020.04.006 Open PDF
     Already cited
124. [R92] Klok, F. A., Kruip, M. J., Meer, N. J. M. V. D., Arbous, M. S., Gommers, D., et al. (2020). Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research, 191, 145–147.
     Source: Thrombosis Research
     DOI: 10.1016/j.thromres.2020.04.013 Open PDF
     Already cited
125. [R146] Klomjit, N., Alexander, M. P., Fervenza, F. C., Zoghby, Z., Garg, A., et al. (2021). COVID-19 Vaccination and Glomerulonephritis. Kidney International Reports, 6(12), 2969–2978.
     Source: Kidney International Reports
     DOI: 10.1016/j.ekir.2021.09.008 Open PDF
     Already cited
126. [R83] Kohli, U., Meinert, E., Chong, G., Tesher, M., & Jani, P. (2020). Fulminant myocarditis and atrial fibrillation in child with acute COVID-19. Journal of Electrocardiology, 73, 150–152.
     Source: Journal of Electrocardiology
     DOI: 10.1016/j.jelectrocard.2020.10.004
     Already cited
127. [R245] Kong, S. L., Chui, P., Lim, B., & Salto‐Tellez, M. (2009). Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients.
     Source: Virus Research
     DOI: 10.1016/j.virusres.2009.07.014
128. [R127] Kotecha, T., Knight, D., Moon, J., Cole, G. D., & Fontana, M. (2021). The evolution of cardiovascular COVID-19 research. European Heart Journal, 42(30), 2953–2954.
     Source: European Heart Journal
     DOI: 10.1093/eurheartj/ehab240 Open PDF
     Already cited
129. [R267] Koyner, J. L. & Murray, P. (2009). Mechanical Ventilation and the Kidney.
     Source: Blood Purification
     DOI: 10.1159/000259585 Open PDF
130. [R57] Kozłowski, P., Leszczyńska, A., & Ciepiela, O. (2024). Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.
     Source: American Journal of Medicine Open
     DOI: 10.1016/j.ajmo.2024.100068
131. [R226] Kumar, G., Jayanti, V., Johnson, M. K., Uchic, J. T., Thomas, S., et al. (2004). Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans.
     Source: Pharmaceutical Research
     DOI: 10.1023/b:pham.0000041457.64638.8d
132. [R155] Kute, V., Godara, S., Goplani, K., Gumber, M. R., Shah, P., et al. (2011). High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury.
     URL: https://pubmed.ncbi.nlm.nih.gov/21196619
133. [R124] Lam (2009). Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors. Archives of Internal Medicine.
     Source: Archives of Internal Medicine
     DOI: 10.1001/archinternmed.2009.384
     Already cited
134. [R191] Lambert, S., Bouttier, M., Vassy, R., Seigneuret, M., Petrow‐Sadowski, C., et al. (2009). HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
     Source: Blood
     DOI: 10.1182/blood-2008-04-150342 Open PDF
135. [R91] Larsen, C. P., Bourne, T. D., Wilson, J. D., Saqqa, O., & Sharshir, M. A. (2020). Collapsing Glomerulopathy in a Patient With COVID-19. Kidney International Reports, 5(6), 935–939.
     Source: Kidney International Reports
     DOI: 10.1016/j.ekir.2020.04.002 Open PDF
     Already cited
136. [R27] Law (2017). Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney International.
     Source: Kidney International
     DOI: 10.1016/j.kint.2017.02.006
     Already cited
137. [R128] Legrand, M., Dupuis, C., Simon, C., Gayat, É., Matéo, J., et al. (2013). Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Critical Care, 17(6), R278.
     Source: Critical Care
     DOI: 10.1186/cc13133 Open PDF
     Already cited
138. [R120] Leisman, D. E., Deutschman, C. S., & Legrand, M. (2020). Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Medicine, 46(6), 1105–1108.
     Source: Intensive Care Medicine
     DOI: 10.1007/s00134-020-06059-6 Open PDF
     Already cited
139. [R3] Li, B., Deng, A., Li, K., Hu, Y., Li, Z., et al. (2022). Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nature Communications, 13(1), 460.
     Source: Nature Communications
     DOI: 10.1038/s41467-022-28089-y Open PDF
     Already cited
140. [R228] Li, L. & Greene, T. (2013). A Weighting Analogue to Pair Matching in Propensity Score Analysis.
     Source: The International Journal of Biostatistics
     DOI: 10.1515/ijb-2012-0030
141. [R176] Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
     Source: Nature
     DOI: 10.1038/nature02145 Open PDF
142. [R6] Li, Z., Wu, M., Yao, J., Guo, J., Liao, X., et al. (2020). Caution on Kidney Dysfunctions of COVID-19 Patients.
     DOI: 10.1101/2020.02.08.20021212 Open PDF
     Already cited
143. [R225] Liamis, G., Rodenburg, E. M., Hofman, A., Zietse, R., Stricker, B. H., & Hoorn, E. J. (2013). Electrolyte Disorders in Community Subjects: Prevalence and Risk Factors.
     Source: The American Journal of Medicine
     DOI: 10.1016/j.amjmed.2012.06.037
144. [R42] Lippi, G., South, A. M., & Henry, B. M. (2020). Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Annals of Clinical Biochemistry International Journal of Laboratory Medicine, 57(3), 262–265.
     Source: Annals of Clinical Biochemistry International Journal of Laboratory Medicine
     DOI: 10.1177/0004563220922255 Open PDF
     Already cited
145. [R18] Liu, J., Li, S., Liu, J., Liang, B., Wang, X., et al. (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 55, 102763.
     Source: EBioMedicine
     DOI: 10.1016/j.ebiom.2020.102763 Open PDF
     Already cited
146. [R7] Liu, T., Zhang, J., Yang, Y., Ma, H., Li, Z., et al. (2020). The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019. EMBO Molecular Medicine, 12(7), e12421.
     Source: EMBO Molecular Medicine
     DOI: 10.15252/emmm.202012421 Open PDF
     Already cited
147. [R85] Liu, Y., Gao, W., Guo, W., Guo, Y., Shi, M., et al. (2020). Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19. Journal of Thrombosis and Thrombolysis, 50(4), 825–832.
     Source: Journal of Thrombosis and Thrombolysis
     DOI: 10.1007/s11239-020-02174-9 Open PDF
     Already cited
148. [R29] Loverre, A., Divella, C., Castellano, G., Tataranni, T., Zaza, G., et al. (2010). T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. Transplant International, 24(3), 233–242.
     Source: Transplant International
     DOI: 10.1111/j.1432-2277.2010.01157.x
     Already cited
149. [R167] Lumley, T. (2004). Analysis of Complex Survey Samples.
     Source: Journal of Statistical Software
     DOI: 10.18637/jss.v009.i08
150. [R35] Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., et al. (2006). Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor–Dependent Mechanism. Hypertension, 48(6), 1050–1057.
     Source: Hypertension
     DOI: 10.1161/01.hyp.0000248135.97380.76 Open PDF
     Already cited
151. [R188] Magnan, A., Mege, J., Escallier, J. C., Brisse, J., Capo, C., et al. (1996). Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group.
     Source: American Journal of Respiratory and Critical Care Medicine
     DOI: 10.1164/ajrccm.153.4.8616577
152. [R45] Mahalingasivam, V., Su, G., Iwagami, M., Davids, M. R., Wetmore, J. B., & Nitsch, D. (2022). COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nature Reviews Nephrology, 18(8), 485–498.
     Source: Nature Reviews Nephrology
     DOI: 10.1038/s41581-022-00570-3 Open PDF
     Already cited
153. [R244] Maison, A. G., Charest, A. F., & Geerts, W. (2005). Anticoagulant Use in Patients with Chronic Renal Impairment.
     Source: American Journal of Cardiovascular Drugs
     DOI: 10.2165/00129784-200505050-00002
154. [R243] Manns, B., Doig, C. J., Lee, H., Dean, S., Tonelli, M., et al. (2003). Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery*.
     Source: Critical Care Medicine
     DOI: 10.1097/01.ccm.0000045182.90302.b3
155. [R142] Marc, G. P., Alvarez‐Paggi, D., & Polack, F. P. (2021). Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine. Journal of Clinical Investigation, 131(12).
     Source: Journal of Clinical Investigation
     DOI: 10.1172/jci150135 Open PDF
     Already cited
156. [R212] Martinez‐Outschoorn, U., Prisco, M. D., Ertel, A., Tsirigos, A., Lin, Z., et al. (2011). Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer.
     Source: Cell Cycle
     DOI: 10.4161/cc.10.8.15330
157. [R72] Martini, A. L., Carli, G., Kiferle, L., Piersanti, P., Palumbo, P., et al. (2022). Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. European Journal of Nuclear Medicine and Molecular Imaging, 50(1), 90–102.
     Source: European Journal of Nuclear Medicine and Molecular Imaging
     DOI: 10.1007/s00259-022-05942-2 Open PDF
     Already cited
158. [R76] Martínez-Rojas, M. A., Vega‐Vega, O., & Bobadilla, N. A. (2020). Is the kidney a target of SARS-CoV-2?. American Journal of Physiology-Renal Physiology, 318(6), F1454–F1462.
     Source: American Journal of Physiology-Renal Physiology
     DOI: 10.1152/ajprenal.00160.2020
     Already cited
159. [R87] McGonagle, D., Sharif, Κ., O’Regan, A., & Bridgewood, C. (2020). The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity Reviews, 19(6), 102537.
     Source: Autoimmunity Reviews
     DOI: 10.1016/j.autrev.2020.102537
     Already cited
160. [R242] Meehan, S. M., Kim, L., & Chang, A. (2012). A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection.
     Source: Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
     DOI: 10.1007/s00428-012-1213-3
161. [R185] Mello, A. F., Juruena, M. F., Pariante, C. M., Tyrka, A. R., Price, L. H., et al. (2007). Depressão e estresse: existe um endofenótipo?.
     Source: Brazilian Journal of Psychiatry
     DOI: 10.1590/s1516-44462007000500004 Open PDF
162. [R82] Minami, T., Iwata, Y., & Wada, T. (2020). Renal complications in coronavirus disease 2019: a systematic review. Inflammation and Regeneration, 40(1), 31.
     Source: Inflammation and Regeneration
     DOI: 10.1186/s41232-020-00140-9 Open PDF
     Already cited
163. [R259] Miyakis, S., Lockshin, M. D., Atsumi, T., Branch, D. W., Brey, R. L., et al. (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
     Source: Journal of Thrombosis and Haemostasis
     DOI: 10.1111/j.1538-7836.2006.01753.x Open PDF
164. [R55] Nader, M., Zmerli, O., Platt, D. E., Hamdan, H., Hamdash, S., et al. (2022). Creatinine levels on admission are main modulators of COVID-19 severity.
     Source: Research Square (Research Square)
     DOI: 10.21203/rs.3.rs-1524668/v1 Open PDF
165. [R56] Nader, M., Zmerli, O., Platt, D. E., Hamdan, H., Hamdash, S., et al. (2022). Observational study of factors associated with morbidity and mortality from COVID-19 in Lebanon, 2020–2021.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0275101
166. [R47] Nahkuri, S., Becker, T., Schueller, V., Maßberg, S., & Bauer‐Mehren, A. (2021). Prior fluid and electrolyte imbalance is associated with COVID-19 mortality. Communications Medicine, 1(1), 51.
     Source: Communications Medicine
     DOI: 10.1038/s43856-021-00051-x Open PDF
     Already cited
167. [R104] Nair, V., Jandovitz, N., Hirsch, J. S., Nair, G., Abate, M., et al. (2020). COVID-19 in kidney transplant recipients. American Journal of Transplantation, 20(7), 1819–1825.
     Source: American Journal of Transplantation
     DOI: 10.1111/ajt.15967 Open PDF
     Already cited
168. [R249] Navar, L. G. (2014). Physiology: hemodynamics, endothelial function, renin–angiotensin–aldosterone system, sympathetic nervous system.
     Source: Journal of the American Society of Hypertension
     DOI: 10.1016/j.jash.2014.05.014 Open PDF
169. [R103] Ng, Y., Li, Z., Chua, Y. X., Chaw, W. L., Zhao, Z., et al. (2020). Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020. MMWR Morbidity and Mortality Weekly Report, 69(11), 307–311.
     Source: MMWR Morbidity and Mortality Weekly Report
     DOI: 10.15585/mmwr.mm6911e1 Open PDF
     Already cited
170. [R180] Nicholls, J. M., Poon, L. L. M., Lee, K. C., Ng, W. F., Lai, S. T., et al. (2003). Lung pathology of fatal severe acute respiratory syndrome.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(03)13413-7 Open PDF
171. [R60] Nomura, E., Finn, L. S., Bauer, A., Rozansky, D. J., Iragorri, S., et al. (2022). Pathology findings in pediatric patients with COVID-19 and kidney dysfunction.
     Source: Pediatric Nephrology
     DOI: 10.1007/s00467-022-05457-w Open PDF
172. [R118] Ocaranza, M. P., Godoy, I., Jalil, J., Varas‐Godoy, M., Collantes, P., et al. (2006). Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat. Hypertension, 48(4), 572–578.
     Source: Hypertension
     DOI: 10.1161/01.hyp.0000237862.94083.45 Open PDF
     Already cited
173. [R270] Occhipinti, P. & Griffiths, P. C. (2008). Quantifying diffusion in mucosal systems by pulsed-gradient spin-echo NMR.
     Source: Advanced Drug Delivery Reviews
     DOI: 10.1016/j.addr.2008.08.006
174. [R240] Ogura, Y., Jesmin, S., Yamaguchi, N., Oki, M., Shimojo, N., et al. (2014). Potential amelioration of upregulated renal HIF-1alpha–endothelin-1 system by landiolol hydrochloride in a rat model of endotoxemia.
     Source: Life Sciences
     DOI: 10.1016/j.lfs.2014.05.007 Open PDF
175. [R129] Pagnesi, M., Baldetti, L., Beneduce, A., Calvo, F., Gramegna, M., et al. (2020). Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart, 106(17), 1324–1331.
     Source: Heart
     DOI: 10.1136/heartjnl-2020-317355
     Already cited
176. [R229] Palm, N. W. & Medzhitov, R. (2007). Not so fast: adaptive suppression of innate immunity.
     Source: Nature Medicine
     DOI: 10.1038/nm1007-1142b Open PDF
177. [R11] Pan, X., Xu, D., Zhang, H., Zhou, W., Wang, L., & Cui, X. (2020). Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Medicine, 46(6), 1114–1116.
     Source: Intensive Care Medicine
     DOI: 10.1007/s00134-020-06026-1 Open PDF
     Already cited
178. [R235] Paul, M., Mehr, A. P., & Kreutz, R. (2006). Physiology of Local Renin-Angiotensin Systems.
     Source: Physiological Reviews
     DOI: 10.1152/physrev.00036.2005
179. [R121] Peng, L., Liu, J., Xu, W., Luo, Q., Deng, K., et al. (2020). 2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples.
     DOI: 10.1101/2020.02.21.20026179 Open PDF
     Already cited
180. [R184] Perani, D., Rosa, P. A. D., Cerami, C., Gallivanone, F., Fallanca, F., et al. (2014). Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
     Source: NeuroImage Clinical
     DOI: 10.1016/j.nicl.2014.10.009
181. [R105] Perotti, L., Baldanti, F., Bruno, R., Fante, C. D., Seminari, E., et al. (2020). Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial. Haematologica, 105(12), 2834–2840.
     Source: Haematologica
     DOI: 10.3324/haematol.2020.261784 Open PDF
     Already cited
182. [R221] Petejová, N. & Martínek, A. (2014). Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.
     Source: Critical Care
     DOI: 10.1186/cc13897 Open PDF
183. [R250] Poteser, M., Graziani, A., Rosker, C., Eder, P., Derler, I., et al. (2006). TRPC3 and TRPC4 Associate to Form a Redox-sensitive Cation Channel.
     Source: Journal of Biological Chemistry
     DOI: 10.1074/jbc.m512205200 Open PDF
184. [R174] Quenot, J., Binquet, C., Vinsonneau, C., Barbar, S. D., Vinault, S., et al. (2015). Very high volume hemofiltration with the Cascade system in septic shock patients.
     Source: Intensive Care Medicine
     DOI: 10.1007/s00134-015-4056-y
185. [R44] Rabaan, A. A., Smajlović, S., Tombuloğlu, H., Ćordić, S., Hajdarević, A., et al. (2022). SARS‐CoV‐2 infection and multi-organ system damage: A review. Biomolecules and Biomedicine, 23(1), 37–52.
     Source: Biomolecules and Biomedicine
     DOI: 10.17305/bjbms.2022.7762
     Already cited
186. [R78] Rana, R., Ranjan, V., Kumar, N., Chugh, P., Khillan, K., et al. (2022). Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study. Molecular and Cellular Biochemistry, 478(1), 149–160.
     Source: Molecular and Cellular Biochemistry
     DOI: 10.1007/s11010-022-04485-2 Open PDF
     Already cited
187. [R216] Recalcati, S., Invernizzi, P., Arosio, P., & Cairo, G. (2008). New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity.
     Source: Journal of Autoimmunity
     DOI: 10.1016/j.jaut.2007.11.003
188. [R219] Reich, H. N., Oudit, G. Y., Penninger, J., Scholey, J. W., & Herzenberg, A. M. (2008). Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease.
     Source: Kidney International
     DOI: 10.1038/ki.2008.497 Open PDF
189. [R122] Remy, K. E., Brakenridge, S. C., François, B., Daix, T., Deutschman, C. S., et al. (2020). Immunotherapies for COVID-19: lessons learned from sepsis. The Lancet Respiratory Medicine, 8(10), 946–949.
     Source: The Lancet Respiratory Medicine
     DOI: 10.1016/s2213-2600(20)30217-4 Open PDF
     Already cited
190. [R93] Risitano, A. M., Mastellos, D. C., Huber‐Lang, M., Yancopoulou, D., Garlanda, C., et al. (2020). Complement as a target in COVID-19?. Nature reviews. Immunology, 20(6), 343–344.
     Source: Nature reviews. Immunology
     DOI: 10.1038/s41577-020-0320-7 Open PDF
     Already cited
191. [R254] Rocha‐Pereira, J., Jochmans, D., Dallmeier, K., Leyssen, P., Nascimento, M. S. J., & Neyts, J. (2012). Favipiravir (T-705) inhibits in vitro norovirus replication.
     Source: Biochemical and Biophysical Research Communications
     DOI: 10.1016/j.bbrc.2012.07.034
192. [R204] Rosa, P. A. D., Cerami, C., Gallivanone, F., Prestia, A., Caroli, A., et al. (2014). A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia.
     Source: Neuroinformatics
     DOI: 10.1007/s12021-014-9235-4
193. [R224] Rosenberger, P., Schwab, J. M., Mirakaj, V., Masekowsky, E., Mager, A., et al. (2009). Hypoxia-inducible factor–dependent induction of netrin-1 dampens inflammation caused by hypoxia.
     Source: Nature Immunology
     DOI: 10.1038/ni.1683
194. [R153] Sadat, U., Usman, A., Boyle, J. R., Hayes, P. D., & Solomon, R. (2015). Contrast Medium-Induced Acute Kidney Injury.
     Source: Cardiorenal Medicine
     DOI: 10.1159/000430770 Open PDF
195. [R101] Salvarani, C., Dolci, G., Massari, M., Merlo, D. F., Cavuto, S., et al. (2020). Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia. JAMA Internal Medicine, 181(1), 24.
     Source: JAMA Internal Medicine
     DOI: 10.1001/jamainternmed.2020.6615 Open PDF
     Already cited
196. [R123] Sang, L., Chen, S., Zheng, X., Guan, W., Zhang, Z., et al. (2020). The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulmonary Medicine, 20(1), 290.
     Source: BMC Pulmonary Medicine
     DOI: 10.1186/s12890-020-01305-5 Open PDF
     Already cited
197. [R79] Santoriello, D., Khairallah, P., Bomback, A. S., Xu, K., Kudose, S., et al. (2020). Postmortem Kidney Pathology Findings in Patients with COVID-19. Journal of the American Society of Nephrology, 31(9), 2158–2167.
     Source: Journal of the American Society of Nephrology
     DOI: 10.1681/asn.2020050744
     Already cited
198. [R166] Savóia, M. G., Santana, P. R., & Mejias, N. P. (1996). Adaptação do inventário de Estratégias de Coping¹ de Folkman e Lazarus para o português.
     Source: LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
     DOI: 10.1590/s1678-51771996000100009
199. [R173] Schwartz, G. J., Haycock, G. B., Edelmann, C. M., & Spitzer, A. (1976). A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine.
     Source: PEDIATRICS
     DOI: 10.1542/peds.58.2.259
200. [R58] Sekar, P. K. C. & Veerabathiran, R. (2025). COVID-19 associated acute kidney injury.
     Source: Infectious Diseases & Immunity
     DOI: 10.1097/id9.0000000000000160
201. [R75] Serafim, A. D. P., Durães, R. S. S., Rocca, C. C. A., Gonçalves, P. D., Saffi, F., et al. (2021). Exploratory study on the psychological impact of COVID-19 on the general Brazilian population. PLoS ONE, 16(2), e0245868.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0245868
     Already cited
202. [R162] Sevignani, G., Soares, M. F., Marques, G. L., Freitas, A. K. E. D., Gentili, A., et al. (2013). Acute kidney injury in patients infected by H1N1 - clinical histological correlation in a series of cases.
     Source: Brazilian Journal of Nephrology
     DOI: 10.5935/0101-2800.20130030 Open PDF
203. [R138] Shah, A., Gribben, C., Bishop, J. L., Hanlon, P., Caldwell, D., et al. (2021). Effect of Vaccination on Transmission of SARS-CoV-2. New England Journal of Medicine, 385(18), 1718–1720.
     Source: New England Journal of Medicine
     DOI: 10.1056/nejmc2106757 Open PDF
     Already cited
204. [R41] Shakoor, M. T., Birkenbach, M., & Lynch, M. (2021). ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. American Journal of Kidney Diseases, 78(4), 611–613.
     Source: American Journal of Kidney Diseases
     DOI: 10.1053/j.ajkd.2021.06.016 Open PDF
     Already cited
205. [R154] Shirasuna, K., Shimamura, N., Seno, K., Ohtsu, A., Shiratsuki, S., et al. (2015). Moderate Hypoxia Down-Regulates Interleukin-6 Secretion and TLR4 Expression in Human Sw.71 Placental Cells.
     Source: Cellular Physiology and Biochemistry
     DOI: 10.1159/000430181 Open PDF
206. [R252] Shrive, A., Gheetham, G. M., Holden, D. W., Myles, D. A. A., Turnell, W. G., et al. (1996). Three dimensional structure of human C-reactive protein.
     Source: Nature Structural & Molecular Biology
     DOI: 10.1038/nsb0496-346
207. [R59] Shu, Z. (2023). Kidney injury in COVID-19 patients: Clinical manifestations and pathogenesis.
     Source: Open Journal of Clinical and Medical Case Reports
     DOI: 10.52768/2379-1039/2033 Open PDF
208. [R239] Silvester, W. (1997). Mediator removal with CRRT: Complement and cytokines.
     Source: American Journal of Kidney Diseases
     DOI: 10.1016/s0272-6386(97)90541-2
209. [R241] Singbartl, K. & Kellum, J. A. (2011). AKI in the ICU: definition, epidemiology, risk stratification, and outcomes.
     Source: Kidney International
     DOI: 10.1038/ki.2011.339
210. [R192] Singbartl, K., Bishop, J., Wen, X., Murugan, R., Chandra, S., et al. (2011). Differential effects of kidney–lung cross-talk during acute kidney injury and bacterial pneumonia.
     Source: Kidney International
     DOI: 10.1038/ki.2011.201 Open PDF
211. [R189] Smits, S. L., Lang, A. D., Brand, J. M. A. V. D., Leijten, L., IJcken, W. F. J. V., et al. (2010). Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates.
     Source: PLoS Pathogens
     DOI: 10.1371/journal.ppat.1000756 Open PDF
212. [R160] Sohn, M., Arnold, N., Maynard, C., & Hynes, D. M. (2006). Accuracy and completeness of mortality data in the Department of Veterans Affairs.
     Source: Population Health Metrics
     DOI: 10.1186/1478-7954-4-2 Open PDF
213. [R208] Soler, M. J., Wysocki, J., & Batlle, D. (2013). ACE2 alterations in kidney disease.
     Source: Nephrology Dialysis Transplantation
     DOI: 10.1093/ndt/gft320 Open PDF
214. [R197] Song, H., Tu, C., Zhang, G., Wang, S., Zheng, K., et al. (2005). Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.
     Source: Proceedings of the National Academy of Sciences
     DOI: 10.1073/pnas.0409608102
215. [R63] Sorkhi, H., Dooki, M. E., Nikpour, M., Mohammadi, M., Mohammadpour-Mir, A., et al. (2022). COVID-19 and renal involvement in children: a retrospective study. PubMed, 13(Suppl 3), 193–198.
     DOI: 10.22088/cjim.13.0.193
     Already cited
216. [R258] Stockman, L. J., Bellamy, R., & Garner, P. (2006). SARS: Systematic Review of Treatment Effects.
     Source: PLoS Medicine
     DOI: 10.1371/journal.pmed.0030343 Open PDF
217. [R2] Su, H., Yang, M., Wan, C., Yi, L., Tang, F., et al. (2020). Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International, 98(1), 219–227.
     Source: Kidney International
     DOI: 10.1016/j.kint.2020.04.003 Open PDF
     Already cited
218. [R61] Sultan, R. H., Abdallah, M., Ali, T. M., Assal, H. H., Ahmed, A. E., et al. (2022). Correlations between kidney and heart function bioindicators and the expressions of Toll-Like, ACE2, and NRP-1 receptors in COVID-19.
     DOI: 10.1101/2022.04.08.22273322 Open PDF
219. [R114] Suryavanshi, N., Kadam, A., Dhumal, G., Nimkar, S., Mave, V., et al. (2020). Mental health and quality of life among healthcare professionals during the COVID‐19 pandemic in India. Brain and Behavior, 10(11), e01837.
     Source: Brain and Behavior
     DOI: 10.1002/brb3.1837
     Already cited
220. [R210] Sánchez, J. L., Binn, L. N., Innis, B. L., Reynolds, R. D., Lee, T., et al. (2001). Epidemic of adenovirus‐induced respiratory illness among US military recruits: Epidemiologic and immunologic risk factors in healthy, young adults*†.
     Source: Journal of Medical Virology
     DOI: 10.1002/jmv.2095
221. [R96] Taha, M., Sano, D., Hanoudi, S. N., Esber, Z., Elahi, M., et al. (2020). Platelets and renal failure in the SARS-CoV-2 syndrome. Platelets, 32(1), 130–137.
     Source: Platelets
     DOI: 10.1080/09537104.2020.1817361
     Already cited
222. [R86] Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., et al. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular and Molecular Immunology, 17(6), 613–620.
     Source: Cellular and Molecular Immunology
     DOI: 10.1038/s41423-020-0400-4 Open PDF
     Already cited
223. [R230] Takasu, O., Gaut, J. P., Watanabe, E., To, K., Fagley, R. E., et al. (2013). Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis.
     Source: American Journal of Respiratory and Critical Care Medicine
     DOI: 10.1164/rccm.201211-1983oc
224. [R71] Teichmann, P. D. V., Moschetta, M. O., Franco, R. F., Vicari, A. R., Nunes, G. L. D. S., et al. (2022). One-year impact of COVID-19 pandemic on renal replacement therapy and kidney transplantation in a tertiary center in Southern Brazil. Brazilian Journal of Nephrology, 45(2), 210–217.
     Source: Brazilian Journal of Nephrology
     DOI: 10.1590/2175-8239-jbn-2022-0034en Open PDF
     Already cited
225. [R28] Tipnis (2000). A Human Homolog of Angiotensin-converting Enzyme. Journal of Biological Chemistry.
     Source: Journal of Biological Chemistry
     DOI: 10.1074/jbc.m002615200
     Already cited
226. [R25] Tufan, A., Güler, A. A., & Matucci‐Cerinic, M. (2020). COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. TURKISH JOURNAL OF MEDICAL SCIENCES, 50(SI-1), 620–632.
     Source: TURKISH JOURNAL OF MEDICAL SCIENCES
     DOI: 10.3906/sag-2004-168 Open PDF
     Already cited
227. [R74] Turabián, J. L. (2022). Covid-19 Breakthrough Infections In Vaccinated People With Vaccine Booster In 2022 Versus Covid-19 Cases In Unvaccinated People In 2020: A New Disease Whose Clinic we Should Know or Another Cause of The Old Symptoms of The Common Cold?. General medicine and Clinical Practice, 5(2), 01–07.
     Source: General medicine and Clinical Practice
     DOI: 10.31579/2639-4162/060 Open PDF
     Already cited
228. [R163] Ulusoy, Ş., Arı, D., Özkan, G., Cansız, M., & Kaynar, K. (2015). The Frequency and Outcome of Acute Kidney Injury in a Tertiary Hospital: Which Factors Affect Mortality?.
     Source: Artificial Organs
     DOI: 10.1111/aor.12449
229. [R102] Valeri, A. M., Robbins-Juarez, S. Y., Stevens, J. S., Ahn, W., Rao, M. K., et al. (2020). Presentation and Outcomes of Patients with ESKD and COVID-19. Journal of the American Society of Nephrology, 31(7), 1409–1415.
     Source: Journal of the American Society of Nephrology
     DOI: 10.1681/asn.2020040470
     Already cited
230. [R84] Vanmassenhove, J., Kielstein, J. T., Jörres, A., & Biesen, W. V. (2017). Management of patients at risk of acute kidney injury. The Lancet, 389(10084), 2139–2151.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(17)31329-6
     Already cited
231. [R81] Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., et al. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395(10234), 1417–1418.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(20)30937-5 Open PDF
     Already cited
232. [R23] Vecchio, L. D. & Locatelli, F. (2020). Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19. Clinical Kidney Journal, 13(4), 494–499.
     Source: Clinical Kidney Journal
     DOI: 10.1093/ckj/sfaa149 Open PDF
     Already cited
233. [R177] Velthuis, A. J. T. (2014). Common and unique features of viral RNA-dependent polymerases.
     Source: Cellular and Molecular Life Sciences
     DOI: 10.1007/s00018-014-1695-z Open PDF
234. [R260] Verhamme, P., Goossens, G., Maleux, G., Collen, D., & Stas, M. (2007). A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion.
     Source: Journal of Thrombosis and Thrombolysis
     DOI: 10.1007/s11239-006-0006-4
235. [R31] Victorino, G. P., Newton, C., & Curran, B. (2002). Effect of Angiotensin II on Microvascular Permeability. Journal of Surgical Research, 104(2), 77–81.
     Source: Journal of Surgical Research
     DOI: 10.1006/jsre.2002.6412
     Already cited
236. [R220] Vigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993). Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.
     Source: Journal of Clinical Investigation
     DOI: 10.1172/jci116336 Open PDF
237. [R73] Vornicu (2022). Relapse of cryoglobulinemic vasculitis with new-onset severe renal involvement in two patients following mRNA COVID-19 vaccination. Medicine.
     Source: Medicine
     DOI: 10.1097/md.0000000000029431
     Already cited
238. [R143] Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., et al. (2020). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397(10269), 99–111.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(20)32661-1 Open PDF
     Already cited
239. [R200] Wakahara, S., Konoshita, T., Mizuno, S., Motomura, M., Aoyama, C., et al. (2007). Synergistic Expression of Angiotensin-Converting Enzyme (ACE) and ACE2 in Human Renal Tissue and Confounding Effects of Hypertension on the ACE to ACE2 Ratio.
     Source: Endocrinology
     DOI: 10.1210/en.2006-1287
240. [R52] Wang, D. (2020). La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19.
     Source: DSPACE System - Metalibrary (University of the Coast)
     URL: https://revistascientificas.cuc.edu.co/culturaeducacionysociedad/article/view/3200
241. [R51] Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., et al. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China.
     Source: JAMA
     DOI: 10.1001/jama.2020.1585 Open PDF
242. [R223] Wang, H., Zhang, H., Zhang, J., Li, Y., Zhao, B., et al. (2015). Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.
     Source: Nature Communications
     DOI: 10.1038/ncomms7240 Open PDF
243. [R1] Wang, L., Li, X., Chen, H., Yan, S., Dong, L., et al. (2020). Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. American Journal of Nephrology, 51(5), 343–348.
     Source: American Journal of Nephrology
     DOI: 10.1159/000507471 Open PDF
     Already cited
244. [R168] Wang, X., Shi, G. C., Wan, H., Hang, S. G., Chen, H., et al. (2013). Clinical features of three avian influenza <scp>H7N</scp>9 virus‐infected patients in <scp>S</scp>hanghai.
     Source: The Clinical Respiratory Journal
     DOI: 10.1111/crj.12087 Open PDF
245. [R193] Wang, Y., Lin, A., Chao, T., Lu, S., Liu, J., et al. (2004). A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan.
     Source: Intensive Care Medicine
     DOI: 10.1007/s00134-004-2311-8 Open PDF
246. [R217] Waugh, J. M. & Perry, C. M. (2005). Anakinra.
     Source: BioDrugs
     DOI: 10.2165/00063030-200519030-00005
247. [R98] Webster, A. C., Nagler, E., Morton, R. L., & Masson, P. (2016). Chronic Kidney Disease. The Lancet, 389(10075), 1238–1252.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(16)32064-5
     Already cited
248. [R19] Who (2020). WHO Coronavirus Disease (COVID-19) Dashboard. Bangladesh Physiotherapy Journal, 10(1).
     Source: Bangladesh Physiotherapy Journal
     DOI: 10.46945/bpj.10.1.03.01
     Already cited
249. [R139] Wilbers, T. & Koning, M. V. (2020). Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery and filter lifetime. Journal of Critical Care, 60, 103–105.
     Source: Journal of Critical Care
     DOI: 10.1016/j.jcrc.2020.07.025
     Already cited
250. [R30] Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995). Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle Cells. Hypertension, 25(5), 913–917.
     Source: Hypertension
     DOI: 10.1161/01.hyp.25.5.913
     Already cited
251. [R141] Wynberg, E., Han, A. X., Boyd, A., Willigen, H. D. V., Verveen, A., et al. (2022). The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine, 40(32), 4424–4431.
     Source: Vaccine
     DOI: 10.1016/j.vaccine.2022.05.090
     Already cited
252. [R22] Xia, S., Zhang, Y., Wang, Y., Wang, H., Yang, Y., et al. (2020). Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases, 21(1), 39–51.
     Source: The Lancet Infectious Diseases
     DOI: 10.1016/s1473-3099(20)30831-8 Open PDF
     Already cited
253. [R5] Xu, J., Chu, M., Zhong, F., Tan, X., Tang, G., et al. (2020). Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs. Cell Death Discovery, 6(1), 76.
     Source: Cell Death Discovery
     DOI: 10.1038/s41420-020-00307-w Open PDF
     Already cited
254. [R175] Xu, X., Kriegel, A. J., Liu, Y., Usa, K., Mladinov, D., et al. (2012). Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21.
     Source: Kidney International
     DOI: 10.1038/ki.2012.241
255. [R234] Yang, B. (2003). Pharmacokinetics of anakinra in subjects with different levels of renal function.
     Source: Clinical Pharmacology & Therapeutics
     DOI: 10.1016/s0009-9236(03)00094-8
256. [R157] Yang, C., Ma, M., Chien, C., Wu, M., Sun, W., & Chen, C. (2007). Hypoxic preconditioning attenuates lipopolysaccharide‐induced oxidative stress in rat kidneys.
     Source: The Journal of Physiology
     DOI: 10.1113/jphysiol.2006.122747 Open PDF
257. [R106] Yang, W., Greene, S. K., Peterson, E., Li, W., Mathes, R., et al. (2022). Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant. Science Advances, 8(4), eabm0300.
     Source: Science Advances
     DOI: 10.1126/sciadv.abm0300 Open PDF
     Already cited
258. [R179] Yang, Z., Werner, H., Kong, W., Leung, K., Traggiai, E., et al. (2005). Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.
     Source: Proceedings of the National Academy of Sciences
     DOI: 10.1073/pnas.0409065102
259. [R95] Yao, X. H., Li, T. Y., He, Z. C., Ping, Y. F., Liu, H. W., et al. (2020). [A pathological report of three COVID-19 cases by minimal invasive autopsies]. PubMed, 49(5), 411–417.
     DOI: 10.3760/cma.j.cn112151-20200312-00193
     Already cited
260. [R111] Yeung, M. L., Yao, Y., Jia, L., Chan, J. F., Chan, K., et al. (2016). MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nature Microbiology, 1(3), 16004.
     Source: Nature Microbiology
     DOI: 10.1038/nmicrobiol.2016.4 Open PDF
     Already cited
261. [R248] Yiu, H., Graham, A. L., & Stengel, R. F. (2012). Dynamics of a Cytokine Storm.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0045027 Open PDF
262. [R8] Zhang, S., Liu, Y., Wang, X., Li, Y., Li, H., et al. (2020). SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Journal of Hematology & Oncology, 13(1), 120.
     Source: Journal of Hematology & Oncology
     DOI: 10.1186/s13045-020-00954-7 Open PDF
     Already cited
263. [R178] Zhang, T., Chen, H., Liang, S., Chen, D., Zheng, C., et al. (2014). A Non-Invasive Laboratory Panel as a Diagnostic and Prognostic Biomarker for Thrombotic Microangiopathy: Development and Application in a Chinese Cohort Study.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0111992 Open PDF
264. [R53] Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(20)30566-3 Open PDF
265. [R50] Zhou, P., Yang, X., Wang, X., Hu, B., Zhang, L., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin.
     Source: Nature
     DOI: 10.1038/s41586-020-2012-7 Open PDF
266. [R16] Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., et al. (2020). Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. National Science Review, 7(6), 998–1002.
     Source: National Science Review
     DOI: 10.1093/nsr/nwaa041 Open PDF
     Already cited
267. [R133] Zia, S., Bhatti, Y. A., Habib, N., Ali, Z., Akbar, A., & Sohail, B. (2022). Association of Respiratory Tract Infections causing Alterations in Lung Parenchyma and Pulmonary Vasculature with Body Electrolyte Imbalance.
     DOI: 10.53350/pjmhs2216637 Open PDF
     Already cited
268. [R97] Zoccali, C., Vanholder, R., Massy, Z. A., Ortíz, A., Sarafidis, P., et al. (2017). The systemic nature of CKD. Nature Reviews Nephrology, 13(6), 344–358.
     Source: Nature Reviews Nephrology
     DOI: 10.1038/nrneph.2017.52 Open PDF
     Already cited
269. [R116] Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of Medicine, 14(2), 185–192.
     Source: Frontiers of Medicine
     DOI: 10.1007/s11684-020-0754-0 Open PDF
     Already cited
270. [R144] Ünver, S., Haholu, A., & Yıldırım, Ş. (2021). Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine. Clinical Kidney Journal, 14(12), 2608–2611.
     Source: Clinical Kidney Journal
     DOI: 10.1093/ckj/sfab155 Open PDF
     Already cited
271. [R88] Перепелица, С. А. (2022). Diagnostics of macrophage activation syndrome, depending on IL-6 initial level in patients with a novel coronavirus infection. Russian Journal of Infection and Immunity, 12(4), 677–687.
     Source: Russian Journal of Infection and Immunity
     DOI: 10.15789/2220-7619-dom-1905 Open PDF
     Already cited
272. [R67] Федулкина, В. А. & Artamonova, A. A. (2024). Unobvious long-term effects of COVID-19 for kidneys. The literature review.
     Source: Nephrology (Saint-Petersburg)
     DOI: 10.36485/1561-6274-2024-28-2-23-30